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Abstract
Background: Increasing evidence has underscored the role of carcinoma associated fibroblasts (CAF) in tumor growth. 
However, there are controversial data regarding the persistence of inoculated CAF within the tumors. We have 
developed a model in which murine metastatic ductal mammary carcinomas expressing estrogen and progesterone 
receptors transit through different stages of hormone dependency. Hormone dependent (HD) tumors grow only in the 
presence of progestins, whereas hormone independent (HI) variants grow without hormone supply. We demonstrated 
previously that CAF from HI tumors (CAF-HI) express high levels of FGF-2 and that FGF-2 induced HD tumor growth in 
vivo. Our main goal was to investigate whether inoculated CAF-HI combined with purified epithelial (EPI) HD cells can 
induce HD tumor growth.
Methods: Purified EPI cells of HD and HI tumors were inoculated alone, or together with CAF-HI, into female BALB/c 
mice and tumor growth was evaluated. In another set of experiments, purified EPI-HI alone or combined with CAF-HI 
or CAF-HI-GFP were inoculated into BALB/c or BALB/c-GFP mice. We assessed whether inoculated CAF-HI persisted 
within the tumors by analyzing inoculated or host CAF in frozen sections of tumors growing in BALB/c or BALB/c-GFP 
mice. The same model was used to evaluate early stages of tumor development and animals were euthanized at 2, 7, 
12 and 17 days after EPI-HI or EPI-HI+CAF-HI inoculation. In angiogenesis studies, tumor vessels were quantified 5 days 
after intradermal inoculation.
Results: We found that admixed CAF-HI failed to induce epithelial HD tumor growth, but instead, enhanced HI tumor 
growth (p < 0.001). Moreover, inoculated CAF-HI did not persist within the tumors. Immunofluorescence studies 
showed that inoculated CAF-HI disappeared after 13 days. We studied the mechanisms by which CAF-HI increased HI 
tumor growth, and found a significant increase in angiogenesis (p < 0.05) in the co-injected mice at early time points.
Conclusions: Inoculated CAF-HI do not persist within the tumor mass although they play a role during the first stages 
of tumor formation promoting angiogenesis. This angiogenic environment is unable to replace the hormone 
requirement of HD tumors that still need the hormone to recruit the stroma from the host.
Background
Breast cancers are comprised of epithelial neoplastic cells
embedded in a tumor microenvironment composed
mainly of extracellular matrix and non-neoplastic cells
such as inflammatory cells, vascular cells and fibroblasts
[1]. Fibroblasts growing within the tumor mass are
known as carcinoma-associated fibroblasts (CAF). They
express smooth muscle actin and are found in large num-
bers in most invasive human breast cancers [2]. There is
increasing evidence that CAF play different roles sup-
porting tumor growth [3]. Several studies have addressed
the role of CAF using experimental designs that involve
the co-inoculation of CAF with breast cancer cell lines in
mice [4,5]. However, the persistence of the inoculated
CAF within the carcinoma remains controversial. Some
authors have reported that they have detected the inocu-
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lated CAF for periods of 30 days or more after the injec-
tion [5,6], suggesting that the tumor stroma was derived
from the inoculated CAF, while others have reported that
the stroma within the tumor was derived from the host
[4,7,8].
In our laboratory, we work with the MPA mouse model
of mammary carcinomas. These tumors were induced by
the continuous administration of medroxyprogesterone
acetate (MPA) in BALB/c mice. Most tumors are initially
hormone dependent (HD) because they grow only if MPA
is supplied. However, they can give rise to different hor-
mone-independent (HI) variants, which are able to grow
without hormone supply. Both HD and HI tumors, have a
rich stromal compartment [9-11]. We have reported that
isolated CAF from our model can be stimulated by EGF,
TGFβ1 and FGF-2 [12], but they are not stimulated by
steroid hormones. In previous studies, we also demon-
strated that primary cultures of isolated CAF from HI
tumors (CAF-HI) induced an increase in cell proliferation
of epithelial cells isolated from HD tumors (EPI-HD).
These CAF-HI express higher levels of fibroblast growth
factor 2 (FGF-2) than CAF from HD tumors (CAF-HD),
and the exogenously administrated FGF-2 induced in
vivo tumor growth of HD tumors in the absence of MPA
[13].
In t his st udy , we wan t ed t o repr oduc e t hese in vitro
findings in an in vivo setting and we hypothesized that
CAF-HI, by secreting FGF-2 or other paracrine factors,
would be able to promote the growth of HD tumor cells.
Our main goal was to evaluate the effect of co-inoculated
CAF-HI on tumor growth of EPI-HD and EPI-HI cells.
This report clearly demonstrates that inoculated CAF-HI
do not persist within the tumor mass although they may
participate during the first stages of tumor growth, favor-
ing angiogenesis. This angiogenic milieu increases HI
tumor growth, although this stimuli is not sufficient to
replace the hormone requirement of HD tumors.
Methods
Animals
Two-month-old virgin female BALB/c mice (Animal
Facility, Instituto de Biología y Medicina Experimental)
were housed in groups of four per cage. Transgenic mice
expressing enhanced GFP under the direction of the
human ubiquitin C promoter were purchased from the
Jackson Laboratories, Bar Harbor, Maine. These mice
express Green Fluorescent Protein (GFP) in all tissues
examined. The animals were in an air-conditioned room
at 20 ± 2°C with a 12-hour light/dark cycle and had access
to food and water ad libitum. Animal care and manipula-
tion were in agreement with institutional guidelines and
the Guide for the Care and Use of Laboratory Animals
[14]. Protocols are approved by the Institutional Bioethi-
cal Committee.
Tumors
C4-HD, a transplantable ductal mammary tumor, was
originally induced by the continuous administration of
MPA to a BALB/c female mouse [9,15] and was subse-
quently maintained by serial subcutaneous (sc) transplan-
tations into syngeneic MPA-treated female mice. This
HD tumor expresses high levels of estrogen (ER) and pro-
gesterone receptors (PR) [16] and shows a nearly diploid
karyotype [17]. The C4-HI variant arose from the C4-HD
tumors when it started to grow in the absence of MPA.
C4-HI cells also exhibit high ER and PR levels but have
acquired an aneuploid karyotype [17,18].
Primary cultures
Primary cultures were prepared from C4-HI and C4-HD
tumors as described previously [16,19]. Briefly, tumors
were aseptically removed, minced, washed with DMEM/
F12 medium (Dulbecco's modified Eagle's medium:
Ham's F12, 1:1, without phenol red, Sigma Chem. Co.),
suspended in 5 ml of enzymatic solution [2.5 mg/ml
trypsin (Life Technologies Inc.), 5 mg/ml albumin (Life
Technologies Inc.), and 850 U/ml collagenase type II (Life
Technologies Inc.) in phosphate buffered saline], and
incubated at 37°C for 20 minutes with continuous stir-
ring. The liquid phase of the suspension was then
removed, and the undigested tissue was incubated for an
additional 20 minutes with fresh enzymatic solution.
Enzyme action was interrupted by adding a washing
medium with 10% fetal calf serum (FCS, BioSer, Buenos
Aires, Argentina). Epithelial (EPI) and fibroblastic cells
(CAF) were isolated by resuspending the digested mate-
rial in 20 ml of medium plus 10% FCS and allowing it to
settle for 20 minutes. The upper 7 ml, containing single
c e l l s ,  w e r e  s e e d e d  i n t o  p l a t e s  a n d  t h e  m e d i u m  w a s
changed after two hours. This time period is enough for
the CAF to settle and not enough for the EPI to attach to
the plastic plates. The fraction corresponding to the
lower 5 ml, containing the sedimented cells, was resus-
pended in another 20 ml of washing medium (plus 5%
FCS) and allowed to settle for 20 minutes. The upper 15
ml were discarded and the procedure was repeated 10
times, or until no single cells were observed in the upper
fraction. Instead of plating the purified EPI, they were
directly used for in vivo experiments. CAF, on the other
hand, were obtained from primary cultures that were
grown for one week prior to inoculation.
Immunofluorescence
Purified EPI-HI, CAF-HI or EPI-HI+CAF-HI were
seeded onto chamber slides. Slides were fixed with 100%
ethanol for 30 minutes at -20°C, washed and treated with
0.25% Triton X-100 for 20 minutes. Slides were rinsed
and blocked with 5% FCS for one hour at room tempera-
ture. Incubation with cytokeratin (CK; polyclonal rabbitFabris et al. BMC Cancer 2010, 10:293
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antibody Z0622, 1:250 dilution, DakoCytomation,
Carpinteria, CA) or smooth muscle actin (SMA; mono-
clonal mouse antibody Sigma Aldrich) was performed
overnight at 4°C. After rinsing in PBS, slides were incu-
bated with fluorescein isothiocyanate (FITC)-conjugated
anti-rabbit (for CK) or anti-mouse (for SMA) IgG at 1:100
dilution (Vector Laboratories, Burlingame, CA). Nuclei
were counterstained with propidium iodide (PI). The sig-
nal was viewed in a Nikon Eclipse E800 confocal micro-
scope.
In vivo experiments
Tumor growth
In the first set of experiments, untreated female BALB/c
mice were sc inoculated with 1.5 × 104 EPI-HD or EPI-HI
alone or together with the same number of CAF-HI (n = 6
m i c e / g r o u p ) .  I s o l a t e d  C A F - H I  w e r e  a l s o  i n o c u l a t e d  t o
rule out the possibility that contaminating EPI-HI cells
could account for the observed effects. In the second set
of experiments, 1.5 × 104  EPI-HI or EPI-HI+CAF-HI
were sc inoculated in untreated female BALB/c mice and
the animals were euthanized at 2, 7, 12 and 17 days post-
inocula (n = 3/group). These cell injections were mixed
with trypan blue prior to inoculation to localize the area
of inoculation. After removal, isografts were immediately
fixed in 10% formalin, embedded in paraffin and pre-
pared for histological evaluation.
Tracking inoculated CAF-HI
Female CAF-HI in male BALB/c mice
EPI-HI (1.5 × 104) alone or together with an equal num-
ber of CAF-HI were sc inoculated into female (n = 4-6/
gr oup )  o r m a le  u n t r ea t ed BALB/ c m ic e  ( n =  4/ gr ou p ) .
Animals were followed closely, and tumor width and
length were measured 3 times a week using a Vernier Cal-
iper. Animals were euthanized after one month. Some of
the tumors were frozen for in situ hybridization studies.
GFP-labeled CAF-HI in BALB/c mice
EPI-HI (1.5 × 104) alone or together with an equal
amount of CAF-HI-GFP were sc inoculated in BALB/c
mice. Trypan blue was used to visualize the site of injec-
tion.
Unlabeled CAF-HI in BALB/c-GFP mice
EPI-HI (1.5 × 104) alone or together with an equal
amount of unlabeled CAF-HI were sc inoculated in
BALB/c-GFP. Trypan blue was used to visualize the site
of injection.
Tumor transplant growing in BALB/c-GFP mice transplanted 
in BALB/c mice
EPI-HI were sc inoculated into BALB/c-GFP mice. Once
the tumor grew a small piece was transplanted into
BALB/c mice.
For all in vivo experiments performed with BALB/c-
GFP mice or inoculated CAF-HI-GFP, before the tumors
were excised, the animals were perfused with a cold saline
solution (0.9% NaCl) followed by 4% paraformaldehyde
(PFA). The inoculated area was excised at different time
points (4, 7, 13 and 28 days), kept in cold 4% PFA over-
night and then transferred to 20% sucrose for another 24
hours. Tissues were embedded in OCT (Tissue-Tek
O.C.T Compound), frozen sections were cut and the
endogenous fluorescence was analyzed by confocal
microscopy. Nuclei were counterstained with PI. Primary
cultures followed by SMA immunostaining were per-
formed with some of these tumors.
Mast and PMN cell quantification
BALB/c mice (n = 3-10/group) were sc inoculated with
saline, CAF-HI (1.5 × 104), EPI-HI (1.5 × 104), or EPI-
HI+CAF-HI (1.5 × 104 + 1.5 × 104). Trypan blue was used
to visualize the site of injection. The animals were eutha-
nized at 7 and 12 days post inocula; tumors were then
fixed with 10% formalin and embedded in paraffin.
Mast cells-toluidine blue method
Tumor sections were deparaffinized and rehydrated,
stained for 30 minutes in aqueous toluidine blue (0.1% pH
1), washed and nuclei were counterstained with methyl
green. Tissues were dehydrated and mounted on Per-
mount and observed under a microscope. Mast cells were
identified by their characteristic metachromasia. Total
mast cells within the inoculated area were counted using
a Nikon Eclipse E200 microscope, magnification 400×.
The tumor area was measured using "Image J" Software
and the numbers of mast cells were calculated per area.
Polymorphonuclear cells quantification
Hematoxylin and eosin (H&E) staining was observed
under a Nikon Eclipse E200 microscope. PMN cells were
identified by standard morphological criteria (Magnifica-
tion: 1000×). All fields within the inoculated area were
counted and PMN numbers of cells were referred per
field.
Fluorescence in situ hybridization (FISH) and 
immunofluorescence
Frozen tissue sections of the tumors were fixed in a cold
solution of methanol:acetic acid (3:1) for one hour. The
tissue sections were denatured in 70% formamide/2×
standard saline-citrate. Mouse paint biotinylated DNA
probes (Cambio, Cambridge, UK) for chromosomes X
and Y were denatured and preannealed. The hybridiza-
tion was performed overnight at 37°C. After hybridiza-
tion, the slides were washed and the probes were detected
with Avidin-TexasRed (Vector Laboratories, Burlingame,
CA). Immunofluorescence using a CK antibody (poly-
clonal rabbit antibody Z0622, 1:250 dilution, DakoCyto-
mation, Carpinteria, CA) was performed on the sameFabris et al. BMC Cancer 2010, 10:293
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slides. A secondary anti-rabbit-FITC coupled antibody
was used. Nuclei were counterstained with DAPI. The
signal was viewed in a Nikon Eclipse E800 confocal
microscope.
Angiogenesis assay in vivo
Each BALB/c mouse was implanted intradermally on the
ventral surface with the cells. Saline, CAF-HI (1.5 × 104),
EPI-HI (1.5 × 104) or EPI-HI+CAF-HI (1.5 × 104 + 1.5 ×
104) were injected in a volume of 50 μl together with one
drop of 0.4% trypan blue to visualize the sites of injection.
After 5 days, the mice were sacrificed, the skin carefully
separated, and photographs captured under a Trinocular
Zoom Stereomicroscope (Leica). The number of vessels
was scored using a grid, subdivided into squares of 0.16
mm2, and superimposed onto the photograph of the
injection site.
Statistical Analysis
Tumor growth curves were studied using regression anal-
ysis and the slopes were compared using ANOVA fol-
lowed by parallelism analysis. Unpaired t-tests were used
as needed. Values are considered significant if p < 0.05.
Results
Effect of CAF-HI on HD and HI tumor growth in vivo
Primary cultures from HD and HI tumors were gener-
ated, and the epithelial cells (EPI) and CAF were sepa-
rated as described in Materials and Methods. We verified
the purity of both cell populations by immunostaining.
Isolated EPI strongly expressed CK whereas CAF
expressed the fibroblastic marker SMA (Figure 1A) and
vimentin (data not shown). This method proved to be
very effective for the isolation of EPI. As confirmed by
CK staining, a purity of 99 ± 0.5% could be attained. CAF
enriched cultures were 93 ± 9.8% pure. To assess the con-
tribution of CAF-HI to HD tumor growth, we inoculated
these cell populations either alone or in combination. In
other words, we mixed CAF-HI with EPI-HD or EPI-HI
cells in a 1:1 ratio and inoculated these mixtures sc in
BALB/c mice. We also inoculated EPI-HD, EPI-HI and
CAF-HI alone. EPI-HI co-mixed with CAF-HI induced a
significant increase in tumor size at the end of the experi-
ment (Figure 1B), a decrease in tumor take (p < 0.05; EPI-
HI vs. EPI-HI+CAF-HI) and an increase in tumor growth
rate during the first period of tumor development (Slope
EPI-HI: 5.2 ± 0.5 mm2/day; EPI-HI + CAF-HI: 8.3 ± 0.5
mm2/day p < 0.01). To ensure that contaminating EPI
cells could not account for the enhancement of EPI-HI
tumor growth, 2 × 105 and 2.2 × 105 cells (plus 10% EPI-
HI) were inoculated. No differences were observed
between either group (data not shown), indicating that
the inoculated CAF-HI were responsible for promoting
tumor growth. Moreover, no tumor growth was observed
in EPI-HD co-inoculated with CAF-HI. These results
raised two possibilities: CAF-HI do not provide sufficient
stimuli to induce EPI-HD tumor growth, or inoculated
CAF-HI do not remain in the tumor for initial signaling
to induce EPI-HD tumor growth and thus, to bypass the
hormone requirement.
Localization of inoculated CAF-HI at different time points
To address the possibility that inoculated CAF-HI do not
persist in the tumor and that the host stroma forms part
of the tumor mass, we developed a murine isograft model
that enabled us to distinguish the cells that come from the
host from those that come from the donor. Thus, we iso-
lated EPI-HI and CAF-HI from tumors growing in BALB/
c mice and inoculated the neoplastic cells alone or
admixed with CAF-HI in BALB/c-GFP mice. These mice
express the GFP in all tissues examined (Jackson lab
UBC-GFP). As shown in Figure 2A by fluorescent analy-
sis of frozen sections, as early as 13 days after cell injec-
tion, there is already a strong invasion of host stroma
within the tumor mass even in the admixed group. Pri-
mary cultures of these tumors and using an anti-smooth
muscle actin antibody confirmed that all the SMA posi-
tive cells were positive for GFP too (Figure 2B), suggest-
ing that even at early time points after cell inoculation the
inoculated CAF-HI are undetected. These data were sup-
ported by additional assays in which neoplastic female
cells were inoculated alone or admixed with CAF-HI in
male BALB/c mice and the results were analyzed by FISH
(data not shown).
We also performed the opposite experiment. We sepa-
rated CAF-HI from a 28-day HI tumor growing in BALB/
c-GFP mice. As expected, these CAF-HI expressed high
Figure 1 Purified EPI and/or CAF inoculated in vivo. (A) Immuno-
fluorescence of purified EPI-HI, CAF-HI or EPI-HI+CAF-HI. (Upper panel) 
Cytokeratin staining (CK; Rabbit polyclonal antibody Dako). (Lower 
panel) SMA (Mouse monoclonal antibody, Sigma Aldrich). Anti-rabbit 
and anti-mouse secondary antibodies coupled to FITC (Vector Labora-
tories) were used for CK and SMA staining, respectively (green). Cells 
were seeded on chamber slides and fixed in 100% ethanol for 30 min-
utes at -20°C. Immunofluorescence was performed as described in Ma-
terials and Methods. Nuclei were counterstained with PI (red). Original 
magnification: 400×. Bar: 60 μm. (B) Tumor growth of purified EPI-HD 
or EPI-HI cells and CAF-HI (2 × 105 cells) alone or EPI (2 × 105 cells) plus 
CAF-HI (2 × 105) that was implanted sc in female BALB/c mice (n = 6). 
EPI-HI or EPI-HI+CAF-HI were prepared as described in Materials and 
Methods. **: p < 0.01; *: p < 0.05. No tumor growth was observed in EPI-
HD, CAF-HI or EPI-HD+CAF-HI. Tumor size: Mean ± s.e.m.Fabris et al. BMC Cancer 2010, 10:293
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levels of GFP (Figure 3). We then inoculated them with
EPI-HI into BALB/c mice. Inoculated CAF-HI-GFP were
not detected 13 days after transplantation (Figure 4A).
However, the non-fluorescent tumor stroma was posi-
tively stained with SMA in immunofluorescence studies,
demonstrating that the inoculated CAF-HI do not persist
within the tumor and that neoplastic epithelial cells
recruit new CAF from the host (Figure 4B). Furthermore,
primary cultures of these tumors followed by immunoflu-
orescence showed that 100% of SMA positive cells were
negative for GFP (data not shown). In a different set of
experiments, we transplanted EPI-HI into BALB/c-GFP
mice and a small piece of this tumor was transplanted
into BALB/c mice. Fluorescence analysis of frozen sec-
tions displayed similar results: 13 days after tumor trans-
plantation, no GFP stromal cells were detected within the
tumor mass (Figure 5A and 5B), and the non-fluorescent
stroma was stained with SMA (Figure 5D). In addition,
isolated CAF-HI, which were positive for SMA, were
100% negative for GFP (Figure 5C). These results indicate
that even CAF within tumor transplants do not persist in
the tumors after trocar transplantation and neoplastic
cells recruit the stroma from the host.
Effect of CAF-HI on histology during early stages of tumor 
formation
We demonstrated that inoculated CAF-HI do not partici-
pate in HD tumor growth; however, they enhanced HI
tumor growth (Figure 1B). Thus, our next goal was to
investigate the growth-enhancing effects of CAF-HI on
HI tumor growth during the first days of tumor forma-
tion. EPI-HI alone or mixed with CAF-HI were inocu-
lated into female BALB/c mice. At 2, 7, 12 and 17 days
after inoculation, the area of tumor inoculum was excised
and histologically evaluated. At day 2 after cell injection,
inflammatory infiltrates such as monocytes, lymphocytes
and polymorphonuclear leukocytes (PMN) were present
in both groups. There were no evident signs of vascular-
ization and it was clear that the inoculated isografts had
not yet developed into solid tumors (Figure 6). At day 7,
significant differences were observed between both
groups. The mixed isografts generated tumors with duc-
tal and cribiform differentiation, which are the morpho-
logical features of these tumors, that were still absent in
Figure 3 Primary cultures of C4-HI tumors growing in BALB/c-GFP 
mice. CAF-HI-GFP were isolated as described in Materials and Meth-
ods. (Upper panel) Photograph of a primary culture of isolated CAF-HI-
GFP alone or, (lower panel) combined with EPI-HI cells. Notice that ep-
ithelial neoplastic cells are negative for GFP. Original magnification: 
100×; Bar: 30 μm. (upper panel) and 40× Bar: 75 μm (lower panel).
Figure 2 Cryostat sections of isolated EPI-HI or admixed with 
CAF-HI growing in BALB/c-GFP mice. (Upper panel) EPI-HI alone or 
admixed with CAF-HI were sc inoculated and animals were sacrificed 
at 13 or 28 days post inoculation. Before sacrifice, animals were per-
fused with 4% PFA. Cryostat sections were prepared; nuclei were coun-
terstained with PI and sections visualized in a confocal microscope. 
Original magnification: 200×. Bar: 60 μm. (Lower panel) Immunofluo-
rescence for SMA of primary cultures of EPI-HI and EPI-HI+CAF-HI tu-
mors on day 13 after inoculation. Cells were seeded in chamber slides, 
fixed with 10% formalin and immunofluorescence was performed as 
described in Materials and Methods. Nuclei were counterstained with 
PI and slides were visualized in a confocal microscope. Original magni-
fication: 400×. Bar: 60 μm.Fabris et al. BMC Cancer 2010, 10:293
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EPI-HI isografts (Figure 6). Several lymphocytes and
polymorphonuclear cells were observed surrounding the
tumors (Figure 6). Despite the clear differences on tumor
histology observed at day 7, on day 12, the EPI-HI cells
developed tumors that were very similar to the EPI-
HI+CAF-HI carcinomas observed at day 7 (Figure 6). At
subsequent time points, the tumors continued to grow,
although the EPI-HI lesions were always smaller than the
admixed tumors (p < 0.001). Even though EPI-HI
isografts began growing later than EPI-HI+CAF-HI, the
tumor growth rate was similar (Figure 1B). It is evident,
that there are no histological differences in either tumor
except for the lag in the development of the tumor struc-
ture. These results suggested that the inoculated CAF-HI
influence the microenvironment during the first stages of
tumor formation, contributing to early tumor develop-
ment.
Effect of inoculated CAF-HI on tumor angiogenesis
We previously demonstrated that FGF-2, a well known
angiogenic factor [20], exerts a direct proliferative effect
o n  e p i t h e l i a l  H D  a n d  H I  c e l l s  [ 1 3 ]  a n d  t h a t  C A F - H I
express higher levels of FGF-2 than CAF-HD. To investi-
gate if co-inoculated CAF-HI could influence angiogene-
sis during the first stages in tumor development, we
performed intradermal inoculations of saline, CAF-HI,
EPI-HI or EPI-HI+CAF-HI in BALB/c mice. Trypan blue
stain was co-administered with the cells to localize the
site of the inoculum. Mice were sacrificed 5 days after
inoculation and tumor vessels were counted. A signifi-
cant increase in tumor vessels (p < 0.05) was observed in
co-inoculated animals compared to the other groups
(Figure 7). Similarly, endothelial cells were positive for
Von Willebrand factor expression in the vascular struc-
tures at the outside edge of EPI-HI+CAF-HI tumors,
whereas no vessels were evident in EPI-HI isografts at
this time point (data not shown). Collectively, these
results indicate that inoculated CAF-HI induce angiogen-
esis at the site of injection contributing to rapid tumor
formation.
Effect of inoculated CAF-HI on the host immune response
To investigate whether the inoculated CAF-HI could be
modulating the innate host's immune system, we evalu-
ated at 5 days post-inoculum the number of PMN and
Figure 4 Cryostat sections of isolated EPI-HI or admixed with 
CAF-HI-GFP growing in BALB/c mice. (Upper panel) EPI-HI alone or 
admixed with CAF-HI-GFP were sc inoculated and mice were sacrificed 
at 4 or 13 days post inoculation. Before sacrifice, animals were perfused 
with 4% PFA. Cryostat sections were prepared, nuclei were counter-
stained with PI, and sections were visualized in a confocal microscope. 
Original magnification: 100× (Day 4) Bar: 30 μm; 200× (Day 13) Bar: 60 
μm. (Lower panel) Immunofluorescence for SMA on day 13 after injec-
tion for EPI-HI and EPI-HI+CAF-HI tumors. Nuclei were counterstained 
with PI, and the sections were visualized in a confocal microscope. 
Original magnification: 200× (Day 13) Bar: 60 μm.
Figure 5 Transplant of C4-HI tumor growing in BALB/c-GFP mice 
into BALB/c mice. Mice were sacrificed 7 days (A) or 13 days (B-D) after 
transplantation. Before sacrifice animals were perfused as described in 
Materials and Methods and cryostat sections were obtained. (A-B) En-
dogenous GFP labeling was detected under a confocal microscope. (C) 
Primary cultures of 13-day tumors were seeded on chamber slides and 
CAF-HI were immunostained for SMA (red). Original magnification: 
400×; Bar: 45 μm. (D) Cryostat sections of 13-day tumors were immu-
nostained for SMA (green). Nuclei were counterstained with PI. Origi-
nal magnification: 200×; Bar: 60 μm.Fabris et al. BMC Cancer 2010, 10:293
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mast cells using standard morphological criteria and
toluidine blue staining, respectively. Both cell types were
detected but we found no significant differences between
both groups (Figure 8A). To rule out the role of the
immune system we inoculated EPI-HI alone or commin-
gled with CAF-HI into NOD/SCID mice. The tumor
growth pattern in NOD/SCID mice was similar to the
one obtained in BALB/c mice: CAF-HI significantly
enhanced tumor growth throughout the experiment and
the tumor weight at the end of the experiment was signif-
icantly higher in the admixed group (Figure 8B). Because
GFP expressed by inoculated CAF-HI can potentially
elicit an immune response, NOD/SCID mice were used
as recipients. CAF-HI-GFP enhanced tumor growth even
in NOD/SCID mice (data not shown). Collectively, these
data indicate that the host's immune system is not
responsible for the enhanced tumor growth induced by
CAF.
Discussion
The mechanisms underlying hormone independent
tumor growth are still unknown. In a recent study, we
demonstrated that CAF-HI express higher levels of FGF-
2 than CAF-HD. Moreover, we showed that in vitro,
CAF-HI induced a significant increase in HD cell prolif-
eration as compared to CAF-HD. In vivo, the exogenous
inoculation of FGF-2 mimicked the effect of hormones
inducing HD tumor growth [13]. In this study, we chal-
lenged the hypothesis that co-inoculated CAF-HI could
bypass the hormone requirement of HD tumors. We
found that inoculated CAF-HI did not persist within the
tumor and thus, they failed to induce HD tumor growth.
Figure 8 PMN and mast cells at early stages (5 days) of tumor de-
velopment. (A) Hematoxylin and eosin (upper panel) or toluidine blue 
(lower panel) staining of EPI-HI or EPI-HI+CAF-HI isografts. BALB/c mice 
were sc inoculated with CAF-HI and/or EPI-HI cells. Original magnifica-
tion: 100× Bar: 72 μm. (Insets) Magnification showing (upper panel) 
PMN cells or (lower panel) mast cells within the inoculation site. (B) Tu-
mor growth of purified EPI-HI (1.5 × 104 cells) alone or admixed with 
CAF-HI (1.5 × 104) implanted sc in NOD/SCID mice (n = 4-5). EPI-HI or 
EPI-HI+CAF-HI were prepared as described in Materials and Methods. 
***: p < 0.001; **: p < 0.01; *: p < 0.05. Tumor size: Mean ± s.d. (Inset) Tu-
mor weight at the end of the experiment (day 30) for EPI-HI and EPI-
HI+CAF-HI tumors.
Figure 6 Histological examination at early stages of tumor devel-
opment of EPI-HI or EPI-HI+CAF-HI isografts. The isografts were ex-
cised at 2, 7, 12 and 17 days after inoculation. BALB/c mice were sc 
inoculated with CAF-HI and/or EPI-HI cells. Original magnification: 
100×. Bar: 170 μm.
Figure 7 Tumor angiogenesis at early stages of tumor develop-
ment. BALB/c mice were intradermally inoculated with saline, CAF-HI 
(1.5 × 104), EPI-HI (1.5 × 104) or EPI-HI+CAF-HI (1.5 × 104 + 1.5 × 104). 
Mice were sacrificed 5 days after inoculation; the site of injection was 
exposed and viewed under a Trinocular Zoom Stereomicroscope. The 
graph shows the quantification of vessels per area. Vessel density was 
determined using a grid that was superimposed onto the photograph 
at the injection site.Fabris et al. BMC Cancer 2010, 10:293
http://www.biomedcentral.com/1471-2407/10/293
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However, CAF-HI decreased tumor latency and
increased angiogenesis in HI tumors.
CAF have recently been implicated in important
aspects of epithelial solid tumor biology, such as progres-
sion, growth, angiogenesis and metastasis. Several studies
have demonstrated that after tumor or cell transplanta-
tion the cancer cells recruit the stroma from the host. In
2004, using intravital microscopy, Duda et al [7] reported
that the stroma from transplants of mammary cell lines
was fully replaced by the host stroma after 4 weeks of
transplantation. Two years later, Udagawa et al [21], using
a lung cell line in GFP mice, demonstrated that this
occurred several days after transplantation. Therefore, it
is clear that once the tumor is established, the accompa-
nying stroma is recruited from the host. However, in
experiments regarding the inoculation of CAF together
with tumor cells, the persistence of CAF within the tumor
mass is not so well defined. Some studies have indicated
that exogenously inoculated human CAF remain as part
of the tumor stroma at least during the first 30 days [6] or
m o r e  [ 5 ] ,  a n d  o t h e r s  h a v e  r e p o r t e d  t h a t  i n o c u l a t e d
human CAF disappear and the tumor stroma is exclu-
sively of murine origin [4,8]. Here, we demonstrated that
in our model, exogenously administered CAF-HI are
undetectable as early as day 13 after injection. Thus, no
long-lasting effects can be directly attributed to inocu-
lated CAF. Despite their inability to persist, these CAF
can exert growth promoting effects during the first days
after cell inoculation decreasing tumor latency. The short
lifespan of inoculated CAF-HI is not enough to enhance
HD growth, although it rapidly creates a proper microen-
vironment for HI growth.
T h e  f a c t  t h a t  s t r o m a l  c o m p o n e n t s ,  s u c h  a s  C A F  o r
Matrigel, increase the tumor burden is not a novel find-
ing. In fact, this methodology is used to grow cells that
will otherwise not grow [4]. Co-inoculation of fibroblasts
with different tumor cells [4,5,22,23] or with sub-tumori-
genic numbers of epithelial cells [24] has been shown to
promote tumor growth. We found that co-inoculated
CAF-HI enhanced HI tumor growth and that they do not
persist within the tumor. Based on these findings, we
concluded that the growth enhancing effects are a result
of changes occurring during the early stages of tumor
development. However, most studies using admixed CAF
investigate their effects once the tumor is already settled
and, according to our data, these CAF may be those
recruited by the tumor cells [5,6].
To understand the stimulatory effects of CAF on tumor
growth, we also investigated possible differences in the
tumor site microenvironment at early time points after
cell inoculation. We looked for changes occurring in the
site of implantation even before the tumor structure was
organized. In our view, the very first stages in tumor
development are crucial and a fast stromal recruitment
will favor tumor formation and progression. Both, growth
promoting or inhibitory effects have been demonstrated
for certain hematopoietic cells such as: mast cells, neu-
trophils, NK cells or dendritic cells [25,26]. Most of these
studies using CAF and cell lines have been made using
immunocompromised mice. The strength of this study is
that we are working with BALB/c mice and we could not
establish differences in the immune infiltrates that could
account for the differences observed. Moreover, the same
differences in tumor growth were observed in BALB/c
mice and in NOD/SCID mice supporting a non-immune
effect of CAF.
Accumulating evidence suggests a role for fibroblasts
promoting angiogenesis [5,27]. Studebaker et al [28], have
shown that MCF-7 cells co-injected with senescent skin
fibroblasts, which secrete IL-6, developed tumors, while
mice co-injected with pre-senescent skin fibroblasts, that
express little or no IL-6, failed to form tumors. We previ-
ously demonstrated that CAF-HI secrete high levels of
FGF-2 [13]. FGF-2 is a well known angiogenic factor [20]
and here, we showed an increase in angiogenesis when
EPI-HI were co-inoculated with CAF-HI. We can specu-
late that FGF-2 from CAF-HI might be contributing to
the development of a pro-angiogenic milieu creating a
permissive microenvironment that favors tumor growth.
The precise nature and origin of the stromal cells that
grow along with the tumor cells is still a matter of debate.
It has been proposed that CAF are resident fibroblasts
recruited by the tumor [29], that they may arise by an epi-
thelial mesenchymal transition (EMT) of the tumor
parenchyma [30-32], or that they are mesenchymal bone
marrow derived cells recruited from the circulation [21].
Although we cannot yet establish if CAF from our tumors
are resident or bone marrow recruited fibroblasts, we can
rule out the possibility of an EMT as CAF-HI isolated
f r o m  t u m o r s  g r o w i n g  i n  B A L B / c - G F P  m i c e  e x p r e s s e d
GFP.
Conclusions
We demonstrated that co-inoculated CAF-HI did not
provide sufficient stimuli to replace the hormone require-
ment of HD epithelial cells in vivo. However, they facili-
t a t e d  H I  e p i t h e l i a l  g r o w t h  a t  l e a s t  i n  p a r t  b y  f a v o r i n g
angiogenesis. In addition, we demonstrated that the inoc-
ulated CAF are lost in a short period of time after injec-
tion and that tumor cells recruit fibroblasts from the host.
The results suggest that careful controls should be
included in experiments involving inoculated CAF to
draw appropriate conclusions on the biology of cancer.
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